| |
| |
|
| Insider
Information: |
Reasons Bryan M. |
| Relationship: |
Director |
| City: |
Hayward |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
24,072 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$28,886 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
24,072 |
|
|
| Total
Value |
$28,886 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 149.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Impax Laboratories Inc |
IPXL |
Chief Financial Officer |
2018-05-04 |
0 |
|
0 |
Premium* |
|
|
Societal CDMO, Inc |
SCTL |
Director |
2024-04-08 |
0 |
2018-05-04 |
0 |
Premium* |
|
|
Mallinckrodt plc |
MNK |
EVP & CFO |
2023-11-14 |
0 |
2019-04-01 |
0 |
Premium* |
|
|
Aclaris Therapeutics, Inc. |
ACRS |
Director |
2023-06-02 |
24,072 |
2020-03-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2024-04-08 |
4 |
D |
$1.10 |
$80,982 |
D/D |
(73,620) |
0 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2024-04-08 |
4 |
D |
$1.10 |
$239,172 |
D/D |
(217,429) |
73,620 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
EVP & CFO |
• – – |
2023-11-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(96,660) |
0 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2023-08-28 |
4 |
B |
$0.40 |
$25,000 |
D/D |
62,500 |
291,049 |
2.39 |
% |
|
| MNK |
Mallinckrodt plc |
EVP & CFO |
• – – |
2023-08-17 |
4 |
D |
$0.69 |
$11,071 |
D/D |
(15,976) |
96,660 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2023-06-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,507 |
24,072 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2023-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
73,620 |
228,549 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
EVP & CFO |
• – – |
2022-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
112,636 |
112,636 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
EVP & CFO |
• – – |
2022-06-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,593) |
0 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2022-06-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,356 |
19,565 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
87,500 |
154,929 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2021-04-20 |
4 |
A |
$0.00 |
$0 |
D/D |
26,923 |
67,429 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
EVP & CFO |
• – – |
2020-12-03 |
4 |
S |
$0.17 |
$891 |
D/D |
(5,400) |
11,593 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2020-06-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,333 |
16,209 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2020-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
8,363 |
40,506 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
EVP & CFO |
• – – |
2020-04-01 |
4 |
D |
$1.93 |
$1,903 |
D/D |
(986) |
16,993 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2020-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,876 |
8,876 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2019-12-05 |
4 |
A |
$0.00 |
$0 |
D/D |
9,156 |
32,143 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
EVP & CFO |
• – – |
2019-06-07 |
4 |
B |
$8.96 |
$48,383 |
D/D |
5,400 |
17,979 |
2.74 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2019-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
7,955 |
22,987 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
EVP & CFO |
• – – |
2019-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,579 |
12,579 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2018-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,849 |
15,032 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
Chief Financial Officer |
• – – |
2018-05-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(20,566) |
0 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
Chief Financial Officer |
• – – |
2018-05-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(53,423) |
0 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2018-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,183 |
6,183 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
